It was overvalued back then @2 or $40 post consolidation , which could be achieved by expanding women health and specialty products as they achieve higher GP and the contraceptive market in us grows by % 5.6 each year . if you have bought in FEB 2023 your earning per share would have been $ 1.00 per share , if you buy now at discount , 6 month later you could achieve the same , don't miss the opportunity , at least don't sell your shares at discounted price to big retailers . buy now and average down and hold tight until the 1HFY24 update
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)